Lecanemab Gains FDA Approval for Early Alzheimer Disease

被引：56

作者：

Larkin, Howard D. D.

机构：

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2023年 / 329卷 / 05期

关键词：

D O I：

10.1001/jama.2022.24490

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

收藏

页码：363 / 363

页数：1

相关论文

共 50 条

[21] Lecanemab, a Novel Amyloid ß-Directed Antibody for Early Alzheimer Disease
Toderika, Yuliana
Najib, Jadwiga
JNP- THE JOURNAL FOR NURSE PRACTITIONERS, 2023, 19 (09):
[22] Lecanemab: A Humanized Monoclonal Antibody for the Treatment of Early Alzheimer Disease
Park, Juliane
Simpson, Carson
Patel, Katie
ANNALS OF PHARMACOTHERAPY, 2024, 58 (10) : 1045 - 1053
[23] Surgical sealant gains FDA approval to market
不详
ADHESIVES AGE, 2001, 44 (09): : 7 - 7
[24] Chocolate ballon catheter gains FDA approval
Fitzpatrick, Sean
EXPERT REVIEW OF MEDICAL DEVICES, 2012, 9 (02) : 103 - 103
[25] Approval of Aducanumab for Alzheimer Disease-the FDA's Perspective
Dunn, Billy
Stein, Peter
Cavazzoni, Patrizia
JAMA INTERNAL MEDICINE, 2021, 181 (10) : 1276 - 1278
[26] US FDA defends approval of Alzheimer's disease drug
Jaffe, Susan
LANCET, 2021, 398 (10294) : 12 - 12
[27] Controversy and Progress in Alzheimer's Disease - FDA Approval of Aducanumab
Rabinovici, Gil D.
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (09) : 771 - 774
[28] Lecanemab for Alzheimer Disease: Is It Worth It?
Nelson, Sarah E.
Lopez, Oscar L.
NEUROLOGY, 2024, 102 (07)
[29] FDA issues Aricept® approval for severe Alzheimer's disease
不详
PSYCHOPHARMAKOTHERAPIE, 2007, 14 (01): : X - X
[30] Ceritinib Gains FDA Approval for Lung Cancer
不详
CANCER DISCOVERY, 2014, 4 (07) : 753 - 754

← 1 2 3 4 5 →